Dr.ย Samuelย Raphael
MD (Doctor of Medicine)
Head, Breast Cancer Unit
corporate_fareRabin Medical Center / Davidoff Cancer Center, Petah Tikva
Samuel Raphael
MD (Doctor of Medicine)
Prof. Samuel Raphael is a senior breast oncologist and Head of the Breast Cancer Unit at Rabin Medical Center and the Davidoff Cancer Center in Petah Tikva, Israel. With over 20 years of clinical experience, he specialises in the management of complex and aggressive breast cancers including triple-negative breast cancer and BRCA mutation-associated breast cancer.
Prof. Raphael trained at Tel Aviv University and completed further training in the United States, bringing an internationally informed perspective to breast oncology practice in Israel. His clinical work focuses on multidisciplinary treatment planning for early-stage, locally advanced, and metastatic breast cancer, with particular expertise in biomarker-driven systemic therapy selection. He integrates molecular profiling, genetic risk assessment, and modern systemic agents including CDK4/6 inhibitors, PARP inhibitors, immunotherapy, and antibody-drug conjugates into individualised care plans. Davidoff Cancer Center, where Prof. Raphael practices, is one of Israel's most recognised comprehensive cancer centres, offering patients access to advanced diagnostics, clinical trials, and specialist multidisciplinary input under one roof.
Why Consider Prof. Samuel Raphael?
Prof. Raphael brings focused breast oncology expertise and over two decades of clinical experience to the management of difficult breast cancer subtypes. For patients with aggressive or hereditary breast cancer, his multidisciplinary approach and access to Davidoff Cancer Center's infrastructure offer a strong foundation for personalised treatment planning.
Areas of Specialisation
Breast oncology with particular focus on aggressive subtypes and hereditary breast cancer
Prof. Raphael's clinical specialisation covers the full spectrum of breast cancer management, with depth in triple-negative breast cancer, BRCA-associated disease, and advanced metastatic breast cancer requiring complex systemic therapy decisions.
Triple-Negative Breast Cancer
Multidisciplinary treatment planning for one of the most biologically aggressive breast cancer subtypes.
- arrow_rightNeoadjuvant chemotherapy protocols for early-stage TNBC
- arrow_rightImmunotherapy with checkpoint inhibitors for eligible patients
- arrow_rightPathological complete response-guided adjuvant decisions
- arrow_rightBRCA testing and PARP inhibitor evaluation for recurrent or metastatic TNBC
- arrow_rightAntibody-drug conjugates for pre-treated metastatic TNBC
- arrow_rightMolecular profiling to guide later-line treatment choices
- arrow_rightClinical trial evaluation where appropriate
BRCA & Hereditary Breast Cancer
Genetic risk integration and targeted treatment planning for patients with hereditary breast cancer syndromes.
- arrow_rightGermline BRCA1/BRCA2 testing guidance and referral
- arrow_rightPARP inhibitor therapy for eligible BRCA-mutated patients
- arrow_rightCoordination with genetic counsellors and surgical oncologists
- arrow_rightRisk-reducing strategy assessment and family-based risk counselling
Advanced & Metastatic Breast Cancer
Personalised systemic therapy planning for locally advanced and metastatic breast cancer across all receptor subtypes.
- arrow_rightCDK4/6 inhibitor-based regimens for HR-positive advanced disease
- arrow_rightEndocrine therapy sequencing and resistance management
- arrow_rightPI3K/AKT pathway-targeted treatment where applicable
- arrow_rightHER2-directed therapy including trastuzumab-based regimens
- arrow_rightAntibody-drug conjugates for metastatic HER2-positive disease
- arrow_rightDual HER2 blockade strategies in selected patients
Procedures & Treatment Services
Comprehensive systemic oncology care for breast cancer patients
Prof. Raphael's clinical services focus on systemic therapy planning and multidisciplinary breast cancer management, covering neoadjuvant, adjuvant, and metastatic treatment settings.
Systemic Breast Cancer Treatment
Medical OncologyFull-spectrum systemic therapy planning for breast cancer patients across all stages and receptor subtypes.
Targeted & Precision Oncology
Targeted TherapyBiomarker-driven treatment selection using tumour profiling, molecular testing, and genetic risk assessment.
Multidisciplinary Breast Cancer Care
MultidisciplinaryCoordinated input from breast surgeons, radiation oncologists, pathologists, genetic counsellors, and supportive care specialists.
Second Opinion โ Breast Cancer
Second OpinionExpert second-opinion review for breast cancer cases including treatment planning, staging, receptor status interpretation, and therapy selection.
Research & Clinical Contributions
Breast oncology research and clinical expertise at Davidoff Cancer Center
Prof. Raphael is associated with Davidoff Cancer Center, one of Israel's leading cancer research and treatment institutions. His clinical interests align with advances in TNBC management, BRCA-targeted therapy, and modern systemic treatment for metastatic breast cancer.
A detailed publication list may be available through Davidoff Cancer Center or on request via CancerFax.
Education & Training
Prof. Raphael completed his medical training at Tel Aviv University and undertook further clinical training in the United States, building specialist expertise in breast oncology.
Clinical Experience
Prof. Samuel Raphael has over 20 years of experience in breast oncology and currently serves as Head of the Breast Cancer Unit at Rabin Medical Center and the Davidoff Cancer Center in Petah Tikva, Israel.
Languages & International
Prof. Samuel Raphael consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients who require assistance in languages other than English or Hebrew.
CancerFax can coordinate professional medical interpreter support for international patients consulting in other languages.
How CancerFax Helps You Access Dr. Samuel Raphael
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Samuel Raphael's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Samuel Raphael's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Samuel Raphael before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Samuel Raphael's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Samuel Raphael's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Samuel Raphael's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Samuel Raphael
Prof. Samuel Raphael is Head of the Breast Cancer Unit at Rabin Medical Center and Davidoff Cancer Center in Petah Tikva, Israel. He is known for his expertise in breast oncology, with particular focus on triple-negative breast cancer, BRCA mutation-associated breast cancer, and advanced metastatic breast cancer management. He has over 20 years of clinical experience in the field.
Prof. Raphael specialises in the full range of breast cancer subtypes, with particular depth in triple-negative breast cancer (TNBC), BRCA1 and BRCA2 mutation-associated breast cancer, HER2-positive breast cancer, hormone receptor-positive breast cancer, and metastatic or advanced breast cancer. His practice covers early-stage, locally advanced, and metastatic disease in both women and men.
Yes. Triple-negative breast cancer is one of Prof. Raphael's key areas of clinical expertise. TNBC is a biologically aggressive subtype that requires intensive and personalised systemic therapy. Treatment may include chemotherapy, immunotherapy for eligible patients, PARP inhibitors where BRCA mutations are present, and antibody-drug conjugates for advanced or metastatic cases. Genetic testing and clinical trial evaluation may also be discussed.
Yes. International patients may request a second opinion or consultation at Rabin Medical Center / Davidoff Cancer Center, subject to availability and hospital procedures. CancerFax can assist international patients in preparing and organising their medical records, coordinating the submission of documents, and facilitating the consultation process. Please submit your reports through CancerFax to begin.
Patients should prepare the following before requesting a consultation: biopsy and histopathology report, ER, PR, and HER2 status (IHC report), Ki-67 report if available, BRCA1/BRCA2 or other genetic testing results, PET-CT, CT, MRI breast, or bone scan reports, previous chemotherapy or immunotherapy treatment details, surgery and radiation therapy records, current medications, and recent blood test results. CancerFax can help organise and present these documents for submission.
To request a consultation with Prof. Samuel Raphael, submit your medical reports through CancerFax using the upload portal. The CancerFax team will review the documents, prepare the case summary, and coordinate the next steps with the hospital, subject to availability. You may also contact the CancerFax team directly via WhatsApp or email for guidance on the process.
Connect with Samuel Raphael Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.